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Urinary schistosomiasis in France
A healthy 30-year-old man was referred with pain in the right
lumbar region and with a history of macroscopic hematuria. He
had arrived from Mali 5 years previously, and questioning of the
patient revealed that he would often wade barefoot through
freshwater lakes, falls and streams. Findings on physical examina-
tion were unremarkable. The results of blood tests were normal
except for a peripheral blood eosinophilia of 0.65  109/l (10.7%). A
urinary dipstick test was positive for protein and blood. A
computed tomography scan revealed linear calciﬁcation occupying
the entire bladder wall circumference and nearly throughout the
length of the left and right ureters (Figures 1 and 2).1
Figure 1. Maximal intensity projection (A) and volume rendering (B) reconstructions showing calciﬁcations of the urinary tract.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idFigure 2. Initial non-enhanced computed tomography scan showing calciﬁcation of
the bladder wall circumference.The urine sediment allowed the detection and identiﬁcation of
terminally spined Schistosoma haematobium ova.2 Concurrently,
cystoscopy demonstrated a large number of white tubercules
surrounded by a zone of hyperemia in the bladder wall.1201-9712/$36.00 – see front matter  2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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/ International Journal of Infectious Diseases 15 (2011) e506–e507 e507Histological examination of biopsy specimens revealed S. haema-
tobium ova in the submucosa with granuloma formation. The
serum anti-schistosomal antibody measurement was positive by
direct immunoﬂuorescence at 1/160 (positive threshold level, 1/
10).
The patient was successfully treated with praziquantel, given as
a split dose of 40 mg/kg on a single day.3 Timely recognition and
treatment are necessary to prevent the development of Schisto-
soma-related complications, commonly represented by ureteral
obstruction, secondary hydronephrosis or metaplastic cell
changes.4
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